EP 1356295 A2 20031029 - GASTRIC INHIBITORY POLYPEPTIDE DIAGNOSTIC TEST FOR DETECTING SUSCEPTIBILITY TO TYPE-2 DIABETES, IMPAIRED GLUCOSE TOLERANCE, OR IMPAIRED FASTING GLUCOS
Title (en)
GASTRIC INHIBITORY POLYPEPTIDE DIAGNOSTIC TEST FOR DETECTING SUSCEPTIBILITY TO TYPE-2 DIABETES, IMPAIRED GLUCOSE TOLERANCE, OR IMPAIRED FASTING GLUCOS
Title (de)
DIAGNOSTISCER TEST FÜR GASTRIC INHIBITOR PROTEIN ZUR DETEKTION VON ANFÄLLIGKEIT FÜR TYP-II DIABETES, GESTÖRTE GLUKOSETOLERANZ ODER GESTÖRTE GLUKOSE-HOMÖOSTASE
Title (fr)
TEST DE DIAGNOSTIC DE POLYPEPTIDE INHIBITEUR GASTRIQUE DESTINE A LA DETECTION DE LA SENSIBILITE AUX DIABETES DE TYPE 2, A UNE INTOLERANCE AU GLUCOSE, OU A UNE GLYCEMIE A JEUN
Publication
Application
Priority
- US 0113378 W 20010426
- US 55977900 A 20000427
Abstract (en)
[origin: WO0181919A2] Methods and kits for determining whether an individual is susceptible to developing impaired glucose tolerance (IGT), impaired fasting glucose (IFG), or Type-2 diabetes are described. Such methods include administering GIP or GIP variant and nutrient to an individual, measuring the response of the individual and determining whether the individual is susceptible to developing IGT, Type-2 diabetes, or IFG.
IPC 1-7
IPC 8 full level
G01N 33/68 (2006.01)
CPC (source: EP KR)
G01N 33/50 (2013.01 - KR); G01N 33/6893 (2013.01 - EP); G01N 2333/62 (2013.01 - EP); G01N 2800/042 (2013.01 - EP)
Citation (search report)
See references of WO 0181919A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0181919 A2 20011101; WO 0181919 A3 20030424; AU 5727801 A 20011107; CA 2405900 A1 20011101; EP 1356295 A2 20031029; KR 20020097236 A 20021231
DOCDB simple family (application)
US 0113378 W 20010426; AU 5727801 A 20010426; CA 2405900 A 20010426; EP 01930773 A 20010426; KR 20027014447 A 20021026